De Fino, Chiara
 Distribuzione geografica
Continente #
NA - Nord America 1.463
AS - Asia 1.186
EU - Europa 1.098
SA - Sud America 260
AF - Africa 37
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 3
Totale 4.052
Nazione #
US - Stati Uniti d'America 1.437
SG - Singapore 570
DE - Germania 372
CN - Cina 260
SE - Svezia 227
BR - Brasile 218
VN - Vietnam 113
FR - Francia 105
IT - Italia 94
GB - Regno Unito 67
IE - Irlanda 53
IN - India 49
UA - Ucraina 49
ID - Indonesia 43
FI - Finlandia 34
RU - Federazione Russa 29
IQ - Iraq 23
HK - Hong Kong 21
BD - Bangladesh 20
JP - Giappone 20
AR - Argentina 16
TR - Turchia 16
AT - Austria 11
PL - Polonia 10
CI - Costa d'Avorio 9
BE - Belgio 8
NL - Olanda 8
ZA - Sudafrica 8
CA - Canada 7
CL - Cile 7
JO - Giordania 7
MA - Marocco 6
MX - Messico 6
EC - Ecuador 5
IL - Israele 5
IR - Iran 5
SA - Arabia Saudita 5
CO - Colombia 4
ES - Italia 4
KR - Corea 4
NP - Nepal 4
SK - Slovacchia (Repubblica Slovacca) 4
UZ - Uzbekistan 4
VE - Venezuela 4
A2 - ???statistics.table.value.countryCode.A2??? 3
CH - Svizzera 3
KE - Kenya 3
LT - Lituania 3
NZ - Nuova Zelanda 3
PY - Paraguay 3
TN - Tunisia 3
AU - Australia 2
AZ - Azerbaigian 2
BG - Bulgaria 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
EG - Egitto 2
GR - Grecia 2
JM - Giamaica 2
MD - Moldavia 2
MN - Mongolia 2
NI - Nicaragua 2
NO - Norvegia 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AO - Angola 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BS - Bahamas 1
BY - Bielorussia 1
CR - Costa Rica 1
CY - Cipro 1
EE - Estonia 1
ET - Etiopia 1
HT - Haiti 1
HU - Ungheria 1
KH - Cambogia 1
KZ - Kazakistan 1
LB - Libano 1
LI - Liechtenstein 1
LY - Libia 1
MK - Macedonia 1
ML - Mali 1
MY - Malesia 1
NA - Namibia 1
OM - Oman 1
PA - Panama 1
PH - Filippine 1
PK - Pakistan 1
PT - Portogallo 1
QA - Qatar 1
RO - Romania 1
SN - Senegal 1
SV - El Salvador 1
Totale 4.052
Città #
Singapore 333
Chandler 313
San Jose 174
Ashburn 124
Beijing 66
Dublin 53
Los Angeles 40
Jakarta 38
San Mateo 38
Hanoi 37
New York 37
Wilmington 37
Jacksonville 36
Ho Chi Minh City 35
Lauterbourg 33
Nürnberg 31
Boston 27
Milan 26
Nanjing 23
Hong Kong 20
Moscow 19
Munich 19
Princeton 19
Ann Arbor 18
Dallas 17
São Paulo 17
Frankfurt am Main 15
Helsinki 15
Tokyo 15
Cattolica 14
Nanchang 14
Chicago 13
Dearborn 13
Norwalk 13
Rome 13
Hefei 12
Lawrence 12
Houston 11
Shanghai 11
Atlanta 10
Marseille 10
Rio de Janeiro 10
Santa Clara 10
Abidjan 9
Buffalo 9
Chennai 9
London 9
Baghdad 8
Bremen 8
Brussels 8
Falls Church 8
Hebei 8
Nuremberg 8
Woodbridge 8
Amman 7
Brooklyn 7
Dhaka 6
Johannesburg 6
Mountain View 6
Pune 6
The Dalles 6
Amsterdam 5
Düsseldorf 5
Fairfield 5
Haiphong 5
Izmir 5
Kent 5
Lviv 5
Ninh Bình 5
Orem 5
Portsmouth 5
Seattle 5
Tianjin 5
Vienna 5
Andover 4
Ankara 4
Caxias do Sul 4
Coquimbo 4
Council Bluffs 4
Denver 4
Fremont 4
Kunming 4
Leawood 4
Mumbai 4
Redwood City 4
Seoul 4
Stockholm 4
São Gonçalo 4
Tashkent 4
Tehran 4
Turku 4
Warsaw 4
Wroclaw 4
Auckland 3
Augusta 3
Belo Horizonte 3
Brasília 3
Bắc Giang 3
Changchun 3
Changsha 3
Totale 2.139
Nome #
Second-Line Therapy with Fingolimod for Relapsing-Remitting Multiple Sclerosis in Clinical Practice: The Effect of Previous Exposure to Natalizumab 253
Second-Line Therapy with Fingolimod for Relapsing-Remitting Multiple Sclerosis in Clinical Practice: The Effect of Previous Exposure to Natalizumab 176
Sleep Disordered Breathing in a cohort of patients with sporadic Inclusion Body Myositis. 166
Alemtuzumab-induced lung injury in multiple sclerosis: Learning from adversity in three patients 163
Idiopathic inflammatory myopathies evaluated by near infrared spectroscopy 157
Intravascular large B-cell lymphoma presenting as slowly progressive paraparesis with normal MRI features 156
Alemtuzumab-induced lung injury in multiple sclerosis: Learning from adversity in three patients 147
Depression in multiple sclerosis: effect of brain derived neurotrophic factor Val66Met polymorphism and disease perception 137
Disease Reactivation after Fingolimod Discontinuation in Pregnant Multiple Sclerosis Patients 127
The Expanding Role of the Infectious Disease Expert in the Context of the MS Centre 127
A pilot study of lncRNAs expression profile in serum of progressive multiple sclerosis patients 125
Expression Profile of Long Non-Coding RNAs in Serum of Patients with Multiple Sclerosis. 119
Defining the disease course of TNFα blockers-associated Multiple Sclerosis 119
Severe dyspnoea with alteration of the diffusion capacity of the lung associated with fingolimod treatment 113
BDNF rs6265 polymorphism methylation in Multiple Sclerosis: A possible marker of disease progression 113
A unique case of multiphasic ADEM or what else? 113
A pilot study of lncRNAs expression profile in serum of progressive multiple sclerosis patients 111
Is serological response to SARS-CoV-2 preserved in MS patients on ocrelizumab treatment? A case report 110
Anti-cN1A Antibodies Are Associated with More Severe Dysphagia in Sporadic Inclusion Body Myositis 110
CSF CXCL13 and Chitinase 3-like-1 Levels Predict Disease Course in Relapsing Multiple Sclerosis 108
An atypical case of acute disseminated encephalomyelitis associated with cytomegalovirus infection 107
The predictive value of CSF multiple assay in multiple sclerosis: A single center experience 106
Correction: BDNF rs6265 polymorphism methylation in Multiple Sclerosis: A possible marker of disease progression(PLoS ONE (2018) 1310 (e0206140) DOI: 10.1371/journal.pone.0206140) 105
Liver injury after pulsed methylprednisolone therapy in multiple sclerosis patients 104
Magnetic resonance imaging pattern recognition in sporadic Inclusion-Body Myositis 102
Neurosarcoidosis presenting as longitudinally extensive myelitis: Diagnostic assessment, differential diagnosis, and therapeutic approach 94
Focal muscle vibration, an effective rehabilitative approach in severe gait impairment due to multiple sclerosis 93
Exit strategies for “needle fatigue” in multiple sclerosis: a propensity score-matched comparison study 93
The Prevalence of Multiple Sclerosis in the Metropolitan Area of Rome: A Capture-Recapture Analysis 91
Safety and Efficacy of Dimethyl Fumarate in Multiple Sclerosis: An Italian, Multicenter, Real-World Study 90
Delayed hypersensitivity to dimethyl fumarate: Report of 1 case and literature review 88
Identifying Relapses in Multiple Sclerosis Patients through Administrative Data: A Validation Study in the Lazio Region, Italy 79
Sativex® effects on promoter methylation and on CNR1/CNR2 expression in peripheral blood mononuclear cells of progressive multiple sclerosis patients 77
Transient hair loss during treatment with dimethyl-fumarate for multiple sclerosis 73
The predictive value of CSF multiple assay in multiple sclerosis: A single center experience 66
Totale 4.118
Categoria #
all - tutte 17.492
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.492


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202138 0 0 0 0 0 0 0 0 0 0 31 7
2021/2022321 30 6 4 42 12 13 0 50 18 20 46 80
2022/2023730 97 111 65 121 41 87 29 58 70 10 27 14
2023/2024270 18 74 7 7 10 33 20 9 7 10 29 46
2024/2025576 19 23 51 31 32 34 12 19 84 45 129 97
2025/20261.473 236 41 88 163 327 58 281 80 110 88 1 0
Totale 4.118